XSHE
002258
Market cap1.54bUSD
Dec 05, Last price
13.61CNY
1D
4.21%
1Q
9.76%
Jan 2017
53.27%
IPO
111.34%
Name
Lier Chemical Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Lier Chemical Co.,LTD. engages in the research and development, production, and sale of agrochemical products in the People's Republic of China and internationally. The company offers low-toxicity and low-residue safe pesticides, such as chloropyridines and organophosphates. It also provides herbicides, including pinoxaden, glufosinate-ammonium, diquat, flumioxazin, clodinafop-propargyl, clopyralid acid, picloram, fluroxypyr-meptyl, triclopyr, diuron, bensulfuron-methyl, linuron, pyrazosulfuron-ethyl, nicosulfuron, flufenacet, mefenacet, and quinclorac; fungicides, such as azoxystrobin, epoxiconazole, iprodione, and difenoconazole; and insecticides comprising chlorpyrifos and pyriproxyfen, as well as active pharmaceutical ingredients and preparations. In addition, the company offers chemical intermediates, including 2-chloropyridine; 2,3-dichloropyridine; 2,5-dichloropyridine; 2,6-dichloropyridine; 2,3,4-trichloropyridine; 2,3,5-trichloropyridine; 2,3,6-trichloropyridine; nitrapyrin; pentafluoropyridine; 2,3,5,6-tetrachloro-4-methylsulfonylpyridine; 6-chloropyridine-2-carbonitrile; 3,6-difluoropyridine-2-carboxylic acid; 2,2'-bipyridine; 2-chloro-4'-fluoroacetophenone; 2-chloro-2',4'-difluoroacetophenone; and 2-fluoro-3-nitrobenzoic acid. Further, its intermediates comprise (E)-4-(dimethylamino)but-2-enoic acid hydrochloride; 4,4'-dichloro-[3,3']bipyridinyl; clopyralid-methyl; methyl 3,4,6-trichloropicolinate; 2,4,5-trichloropyridine; 7-fluoro-6-nitro-4-hydroxyquinazoline; N-(3-chloro-4-fluorophenyl)-7-fluoro-6-nitroquinazolin-4-amine; 4-bromocrotonic acid; 4-N-(3-chloro-4-fluorophenyl)-7-[(3S)-oxolan-3-yl]oxyquinazoline-4,6-diamine; 2-amino-N-(2-chloro-6-methylphenyl)-1,3-thiazole-5-carboxamide; and 5-chloro-8-hydroxyquinoline. Lier Chemical Co.,LTD. was founded in 1993 and is headquartered in Mianyang, the People's Republic of China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||